Business Program
What Sessions Are Right For You?
Business discipline icons are listed by each session to help you navigate the conference and determine which sessions are right for you. Many sessions may be of interest to you from more than one discipline.
Education Sessions Key |
| To see which sessions pertain to a particular topic, move your mouse over one of the icons below. You can click on a session name in the resulting flyout to jump directly to that session description. |
|
|
|
|
 |
E-Business, MIS/IT, E-commerce, Technical |
 |
Track & Trace, Pedigree, RFID |
 |
Financial, Purchasing, Contract Administration |
 |
Trade/Industry Relations, Sales and Marketing |
 |
Government, Regulatory |
 |
Audience Response Tool |
 |
Supply Chain, Operations, Logistics, Distribution |
|
|
Level of Education
The level of education provided also is identified in the complete session descriptions. The levels are All Levels Welcome; Intermediate and Advanced.
Click on the following to see the business program for each day of the conference.
Monday, March 16 | Tuesday, March 17 | Wednesday, March 18
MONDAY, MARCH 16
Opening General Session | 8:30 AM–9:45 AM
Welcome
John M. Gray, President & CEO, HDMA
HDMA President and CEO John M. Gray will officially open the 2009 DMC & Technology Expo and provide attendees with the latest information on HDMA’s priority efforts in the industry, in the states and on Capitol Hill. Learn more about how HDMA is working across the supply chain to achieve uniform federal pedigree requirements, more efficient and coordinated emergency preparedness continuity plans, implementation of track-and-trace technologies and supply chain best practices.
These efforts are driving innovation to increase supply chain visibility, streamline business efficiencies, enhance supply chain security and further enhance patient safety through partnerships with industry executives, government agencies, legislators, regulators and allied trade associations.
Keynote Address: Relentless Innovation in the Healthcare Supply Chain
Kevin Ashton, Expert on Innovation, Marketing Innovation and RFID
Creating relentless innovation is everyone’s responsibility within a business—especially from front-line employees. Learn about organizational behaviors that help and hinder front-line innovation, how to encourage and develop capabilities and strategies that will enhance your organization.
Keynote speaker Kevin Ashton will present a case study demonstrating how to apply the principles of relentless, front-line innovation. For example, if you deploy radio frequency identification (RFID) technologies to comply with e-pedigree requirements, how can you ensure it delivers a return on investment?
Ashton also will explore the effects and implications for the healthcare supply chain, and how the industry is uniquely challenged by ongoing changes, including:
- The shift to high-volume generics and the need to manage specialty, high-margin biologics;
- Demands for serialized pedigree information and track-and-trace capability;
- Rising transportation costs; and
- New customer demands for business process recovery assurances.
Kevin Ashton is Vice President of Marketing, EnerNOC, a leading innovator in green technology and provider of clean and intelligent energy solutions. Previously, he was Vice President of Marketing & Business Development for ThingMagic; Co-founder of MIT’s Auto-ID Center; Associate Director of Proctor & Gamble; and Lecturer and Visiting Engineer at MIT.
Concurrent Business, Policy & Technology Sessions | 10:00 AM-11:00 AM
Total Recall: Managing an Effective Recall Process
This session is closed to the media to provide an open forum for industry professionals.
Level: Intermediate
When a manufacturer issues a recall/withdrawal notice, a series of events occur at the wholesaler/distributor, hospital and retail pharmacy level to comply with the notice. This session will highlight operational considerations that arise during a recall/withdrawal event and will offer solutions to reduce costs and streamline operations. Wholesaler/distributor, hospital and retail pharmacy perspectives will be presented. All attendees are invited to participate.
Facilitator: Brett Berty, Senior Strategist - Recalls and
Returns, Stericycle
Speakers: Tom Renkey, Principal, TJR Consulting Services; Bea Haupt, JD, CPHQ, Program Manager, Materials Management, Inova Health System; Angelo Voxakis, President, Epic Rx
Unique Location Identification: An Update on Adoption
Level: All Levels Welcome
Discover the elements of the toolkit and how identifiers, including DEA, HIN, DUNs, GLN and more, are being utilized. Get a better understanding of the adoption and usage of these identifiers in your business plan.
Speaker: Robert Kashmer, Vice President, Information Technology, H. D. Smith
Questions & Perspectives: A DEA Update
This session is closed to the media to provide an open forum for industry professionals.
Level: Intermediate
Ask questions and explore perspectives about the upcoming regulatory initiatives of the Drug
Enforcement Administration.
Speaker: Mark Caverly, Chief Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration
Concurrent Business, Policy & Technology Sessions | 11:15 AM-12:15 PM
GS1 and EPCglobal Roadmap: State of Standards
Level: Intermediate
Gain insights to GS1’s and EPCglobal’s broad roadmap that can help companies leverage standards to get started with track-and-trace solutions and standards.
Speaker: Bob Celeste, Director,
GS1 Healthcare US
2008-2009 HDMA Factbook: Facts, Figures and Trends in Healthcare
Level: All Levels Welcome
Get a broader picture of the healthcare supply chain facts, figures and trends through analysis of groundbreaking industry benchmarks reported in the 2008-2009 HDMA Factbook.
Speakers: Rolando DeCardenas, Vice President and General Manager, Pharmaceutical Distribution and Care Advantage, US Oncology; Joseph Perri, Regional Director-East Region, Finance, AmerisourceBergen Corporation; Ed Vianco, Vice President and Controller, McKesson Pharmaceutical Supply Solutions
Update on Reimbursement: AMP and Its Alternatives
Level: Advanced
What is the status of Average Manufacturer Price (AMP) as a reimbursement metric for Medicaid? Could it serve as an alternative to Average Wholesale Price (AWP) if that metric is phased out? What other alternatives exist? In this session, get the latest information on reform of federal reimbursement metrics for pharmaceuticals under Medicaid and Medicare.
Speaker: Larri Short, Partner, Health Law Group, Arent Fox, PLLC
Concurrent Business, Policy & Technology Sessions | 2:15 PM-3:15 PM
Enabling Track & Trace with EPCIS: A Case Study
Level: Intermediate
The use of EPCIS to capture and query supply chain product movement is currently underway in the healthcare industry. Learn about the opportunities from one company currently employing this standard to communicate with supply chain partners.
Speaker: Paul Fowler, Vice President, Healthcare Strategies, Axway, Inc.; Steve Drucker, Director, Global Technical Services, Packaging Technologies & Compliance, Schering-Plough
HDMA EDI Guidelines: Making Channel Data Meaningful
Level: Intermediate
Take a comprehensive look at the newly updated HDMA EDI transactions. Gain insights to the new EDI Usage Guidelines and find out how to leverage EDI, from the 852 and 867, to the 844, 845, 849 and 180.
Speakers: Chris Doerr, Associate Director, Client Financial Services, Cephalon Inc.; Jill Fliehman, Senior Applications Development Consultant – EDI, Cardinal Health, Inc.; Deborah A. Shaw, Director, Implementation, ValueCentric, LLC; Brian Williams, Director, Business Development, GENCO Pharmaceutical Services, formerly Capital Returns
DEA Regulatory Update: Industry Compliance Guidelines (ICG)
Level: Intermediate
This second DEA-focused session will provide attendees an opportunity to hear from AmerisourceBergen, Cardinal Health and Smith Drug Company about how they are working to secure to the supply chain to improve the safety, security and integrity of the medicine supply.
Speakers: Anita T. Ducca, Senior Director, Regulatory Affairs, HDMA; Brad Pine, Director, Compliance & Regulatory Affairs, Smith Drug Company; Mark Hartman, Senior Vice President, Supply Chain Integrity and Regulatory Operations, Cardinal Health, Inc.; Chris Zimmerman, Vice President, Corporate Security and Regulatory Affairs, AmerisourceBergen
Concurrent Business, Policy & Technology Sessions | 3:30 PM-4:30 PM
New Initiatives in Pharmaceutical Waste Management
Level: Intermediate
The pharmaceutical industry, including manufacturers,
distributors and pharmacies, is among the most highly
regulated in the nation. Yet, there is a continuing interest
in understanding the effects of the final disposition of
waste pharmaceuticals. Get updated on the discussion
of pharmaceuticals in the environment and public
health issues; related initiatives at the Environmental
Protection Agency and the Drug Enforcement
Administration [including EPA’s Proposed Rule on the
Amendment to the Universal Waste Rule: Addition of
Pharmaceuticals and DEA’s Advance Notice of Proposed
Rulemaking on the disposal of controlled substances];
and ultimately the effects on the supply chain.
Speaker: Charlotte A. Smith, President,
PharmEcology Associates, LLC
Managing Cold Chain for Temperature-Sensitive Pharmaceutical Products
Level: Intermediate
With the increasing number of products that require cold chain handling, this session will explore how trading partners can more effectively manage cold chain through distribution to the customers. The session begins with the background on cold chain programs in Europe and their applicability to the pharmaceutical supply chain in the U.S. It then moves into a workshop when the attendees can address the potential for developing cold chain pilot programs in the U.S. with an open discussion around objectives, benefits, scope, trading partner and legal requirements and parameters.
Speakers: Ron Bone, Senior Vice President, Distribution Support, McKesson Corporation; Paul Chang, WW Business Strategy for Emerging Technologies, IBM Corporation
Enterprise Risk: Managing the Disruptive Forces Impacting the Health Care Value Chain
Level: Intermediate
In the highly-regulated health care value chain, managing interdependent risks and disruptions can be complex. During this session, learn how to manage enterprise risks, integrate an approach that considers risk-taking for reward and study the principles for transforming your organization into a Risk Intelligent EnterpriseTM.
Speakers: Michael Fuchs, Principal, Deloitte Consulting LLP; Joe Slota, Director, Deloitte Consulting LLP; Bonni Kirkwood, Senior Manager, Life Sciences & Healthcare Strategy & Operations, Deloitte Consulting LLP
TUESDAY, MARCH 17
Morning General Session | 8:30 AM–9:45 AM
iBusiness Solution Awards
The esteemed HDMA iBusiness Solution Awards have honored forward-thinking companies since 1987. These prestigious annual awards recognize HDMA members for technology-enabled process improvements in the healthcare industry. iBusiness Solutions range from innovations of existing systems and business processes, to the unique implementation of cutting-edge technologies with revolutionary process design.
iBusiness Solution Award winners are selected by members of HDMA’s Industry Relations Council based upon the following criteria:
- Value from productivity gained within the healthcare industry
- New or expanded market access
- New services to existing customers
- Improved customer service or satisfaction
- Eliminating time/costs in the healthcare supply chain
- Innovative use of technology
What’s In, What’s Out, What’s Ahead: 2009 Healthcare Marketplace Trends
Doug Long, Vice President, Industry Relations, IMS Health
Get the first look at the latest industry data and emerging market trends for branded pharmaceutical, generic pharmaceutical and health & beauty care product sales from Doug Long of IMS Health. Long is an industry thought leader who specializes in analyzing information from IMS Health’s premier sales, prescription, promotional and medical databases.
Using this data, Long offers perspectives on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends, biotechnology and more. Take advantage of this opportunity to learn how emerging trends will affect strategic business plans in the coming year and beyond.
Doug Long develops information for data partners, and manages supplier, manufacturer and association relationships. He has considerable experience with the changing U.S. and global healthcare marketplaces, as well as insight into healthcare distribution. Prior to IMS Health, Long worked at Nielsen Market Research for 16 years in various sales and marketing capacities. Long received a BA from DePauw University and an MBA in Management from Fairleigh Dickinson University.
Concurrent Business, Policy & Technology Sessions | 10:00 AM-12:00 PM (2-hour sessions)
In-transit Security Practices
This session is closed to the media to provide an open forum for industry professionals.
Level: Advanced
Learn about successful practices to help boost in-transit protection. Explore challenges, discover best practices and focus on formulating new tactics to combat cargo theft and pharmaceutical diversion while in transit.
Speaker: Charles Forsaith, Director, Supply Chain Security, Purdue Pharma L.P.
Demand Planning: Unclogging the Pipes
Level: Advanced
Optimizing supply chain management processes and seeing continual improvement in inventory planning has new meaning in today’s economy. Build on lean principles and six sigma logistics concepts discussed at the 2008 DMC in this advanced look at sales and operations planning. With a fresh take on demand planning and inventory classification, you will hear how the cash to cash cycle time can be reduced as you gain visibility through simple tools and analysis. Learn how to identify variation in the supply value chain in new ways, to understand total costs at the SKU level, and to identify factors leading to profit erosion. Link your S&OP process and improve your strategic (supplier/customer) partnerships. This comprehensive 2-hour session will give you an introduction to Flow Duration Management TM that you can translate to tangible lessons across multiple functional areas in your organizations.
Speakers: Brian K. Cain, CPA, President, The KMW Group, LLC; Steve T. Gran, Principal, Blueprint 57
State and Federal Pedigree Update
Level: Intermediate
As pedigree requirements continue to evolve in the states, federal discussion of this issue has also increased with the introduction of legislation last year. Find out more about the latest changes in state pedigree requirements in addition to an update on federal activity. A panel discussion involving key Congressional staff will talk about the latest action on Capitol Hill.
Speakers: Elizabeth A. Gallenagh, Esq., Vice President, Government Affairs, HDMA; Allison Hite, Legislative Assistant, Representative Steve Buyer, U.S. House of Representatives; Sieglinde (Missy) Johnson, Senior Legislative Assistant, California Senate Business and Professions Committee; Daniel G. Bellingham, Director, State Government Affairs, Healthcare Distribution Management Association; Amy Muhlberg, Senior Health Policy Advisor, Senate Committee on Health, Education, Labor and Pensions
Concurrent Business, Policy & Technology Sessions | 1:30 PM-2:30 PM
Making the Case: Experiences with Serialization, Pedigree and Track & Trace
Level: Intermediate
Attend to hear updates on pilot programs, case studies and highlights of track-and-trace implementation advancements. Come ready to share your comments, questions and insights!
Speaker: Michelle L. Keller, Product Safety & Integrity Manager, TEVA Pharmaceuticals USA; Kevan MacKenzie, Senior Solutions Analyst, McKesson Pharmaceutical
FDA’s New Focus on Safety & Risk Management
Level: Advanced
Discuss how FDA is implementing FDAAA’s Risk Evaluation & Mitigation Strategies (REMS) provisions, including restricted distribution definitions. Find out how REMS could affect your company and come prepared to share your insights and approaches to REMS strategies and compliance efforts.
Speakers: Ronald W. Buzzeo, R.Ph., Chief Regulatory Officer, Cegedim Dendrite Compliance Solutions, Powered by BuzzeoPDMA; Brian P. Waldman,
Partner, Arent Fox LLC
WEDNESDAY, MARCH 18
Morning General Session | 8:30 AM–9:30 AM
A View From the Customer: Panel Discussion
Panel Moderator: Bob Dufour, COO, Blue Ocean Innovative Solutions
The healthcare supply chain exists to safely and efficiently serve more than 145,000 pharmacy settings across the United States. Distributors and manufacturers work together every day to reduce costs and enhance services. But the needs of various customers—and ultimately patients—drive business. This panel discussion, moderated by industry veteran Bob Dufour, provides a look into customer expectations, needs and challenges, and explores how customers view working with the supply chain.
Bob Dufour is COO of Blue Ocean Innovative Solutions and a pharmacist with 24 years of experience at Wal-Mart. He has extensive experience working within the pharmacy industry covering a broad variety of issues, including mail order pharmacy, pharmacy operations, specialty pharmacy, PBMs, third-party contracting, manufacturer programs, professional services and government relations. Dufour currently is the President of the Arkansas Board of Pharmacy. He has received numerous awards and is recognized as a leader in the retail pharmacy industry. Dufour received his BS in Pharmacy from the School of Pharmacy, University of Louisiana at Monroe.
Panelists:
Dave Fong, Senior Vice President, Pharmacy, Safeway, Inc.; John Foss, RPh, Director of Outpatient Pharmacy & Pharmacy Informatics, Memorial Health System; Debbie Garza,
Divisional Vice President, Government and Community Relations, Walgreens;
Joe Lewis, Drug Diversion Control Officer, Parkland Hospital
Closing General Session | 9:45 AM–11:00 AM
The First 100 Days: A Look into the New Presidential Administration
Howard Fineman, Senior Washington Correspondent and Political Columnist, Newsweek
The first major challenge for any new Administration is the 100-day benchmark. While the new President will have ideas and goals for the first 100 days, there will be numerous hurdles and challenges to overcome. The transition from campaigning to governing is a demanding task, given the intense media focus, party politics and competing priorities. Hear an insider’s perspective on how President-elect Obama is managing the challenging task of leading the nation. Perspectives also will include the necessity of balancing party politics with the need to solve the country’s pressing issues, including energy and healthcare, while offering analysis and observations on the issues and players in the White House and on Capitol Hill.
Howard Fineman is Newsweek’s Senior Washington Correspondent and Columnist, and is one of the nation’s leading political reporters and commentators. Fineman also contributes to the Today Show, MSNBC’s Hardball with Chris Matthews and Countdown with Keith Olbermann. He is the author of many Newsweek cover stories, and has interviewed and written about every President and major presidential contender since 1987. He recently published his first book, The Thirteen American Arguments: Enduring Debates That Define and Inspire Our Country. He earned an AB from Colgate University; an MS in Journalism from Columbia University; and a JD from the Brandeis School of Law at the University of Louisville.
For more information, please contact:
Registration and Exhibits: Vicki Lindberg, Manager, Meetings & Education, (703) 885-0280.
Business Program: Tirza Niemann, Director, Meetings & Education, (703) 885-0230.
|
